People with Fabry disease who have burning limb pain or depression are more likely to report poor quality of…
Articles by Marisa Wexler, MS
A gene therapy treatment increased levels of the deficient alpha-glactosidase A (Gal A) enzyme in the organs of mice in…
Enzyme replacement therapy (ERT) can help to increase the bone density of male patients with Fabry disease, who…
An imaging technology called 3D echocardiography, which allows clinicians to visualize the heart in three dimensions and measure the strain…
People with Fabry disease commonly have abnormalities in the brain’s blood vessels, such as unusually thick vessel walls or…
Looking for abnormal, clumped features — dubbed mulberry bodies by scientists — in cells of a person’s urine may be…
ST-920 (isaralgagene civaparvovec), an experimental gene therapy for Fabry disease that’s currently headed toward Phase 3 clinical testing,…
In Fabry disease, a protein called alpha-synuclein forms clumps inside kidney cells, a toxic buildup that isn’t reversed by…
Freeline Therapeutics is pausing development of FLT190, an experimental gene therapy for Fabry disease. The move will…
The same mutation caused both late-onset and classic forms of Fabry disease among different members of the same family,…